| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |